Fundz

Correlia Biosystems reported raising $1.25 Million in an initial SEC Form D filing, from an offering of $3.25 Million

PRIVATEMay 09, 2023$1.3M of $3.3M raised

Amount Raised

$1.25 Million

$1.25 Million sold, per SEC Form D (first sale May 1, 2023)

Round Type

Seed

BerkeleyBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Correlia Biosystems, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Beekeeper's Naturals raised $14M (Funding Round) on June 15, 2023.
  • Neuvivo raised $11M (Funding Round) on June 15, 2023.
  • Metagen Therapeutics raised an undisclosed amount (Series A) on June 15, 2023.
  • Theradaptive raised $26M (Series A) on June 15, 2023.
  • Zucara Therapeutics raised an undisclosed amount (Funding Round) on June 15, 2023.
  • Beyond Air raised $40M (Debt Financing) on June 15, 2023.

Who to call at Correlia Biosystems, Inc., and when

A new round usually means Correlia Biosystems, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Correlia Biosystems, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Correlia Biosystems, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Correlia Biosystems, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Correlia Biosystems, Inc.

Location

626 BANCROFT WAY

Berkeley, California, United States

About

Correlia Biosystems is a UC Berkeley spinoff company based out of the QB3@953 startup incubator in San Francisco. Correlia develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. Our versatile "SimpleScan"​ technology opens up new biological questions from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Correlia Biosystems, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSamuel T., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Correlia Biosystems, Inc.'s next move

See what Strategic adds

Correlia Biosystems, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.